Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort
Top Cited Papers
- 1 March 2012
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 33 (3), 250-256
- https://doi.org/10.1086/664049
Abstract
Objective.: To evaluate the economic impact of ventilator-associated pneumonia (VAP) on length of stay and hospital costs.Design.: Retrospective matched cohort study.Setting.: Premier database of hospitals in the United States.Patients.: Eligible patients were admitted to intensive care units (ICUs), received mechanical ventilation for ≥2 calendar-days, and were discharged between October 1, 2008, and December 31, 2009.Methods.: VAP was defined by International Classification of Diseases, Ninth Revision (ICD-9), code 997.31 and ventilation charges for ≥2 calendar-days. We matched patients with VAP to patients without VAP by propensity score on the basis of demographics, administrative data, and severity of illness. Cost was based on provider perspective and procedural cost accounting methods.Results.: Of 88,689 eligible patients, 2,238 (2.5%) had VAP; the incidence rate was 1.27 per 1,000 ventilation-days. In the matched cohort, patients with VAP (n = 2,144) had longer mean durations of mechanical ventilation (21.8 vs 10.3 days), ICU stay (20.5 vs 11.6 days), and hospitalization (32.6 vs 19.5 days; all P< .0001) than patients without VAP (n = 2,144). Mean hospitalization costs were $99,598 for patients with VAP and $59,770 for patients without VAP (P< .0001), resulting in an absolute difference of $39,828. Patients with VAP had a lower in-hospital mortality rate than patients without VAP (482/2,144 [22.5%] vs 630/2,144 [29.4%]; P<.0001).Conclusions.: Our findings suggest that VAP continues to occur as defined by the new specific ICD-9 code and is associated with a statistically significant resource utilization burden, which underscores the need for cost-effective interventions to minimize the occurrence of this complication.Infect Control Hosp Epidemiol 2012;33(3):250-256Keywords
This publication has 12 references indexed in Scilit:
- Long‐Term Impact of a Multifaceted Prevention Program on Ventilator‐Associated Pneumonia in a Medical Intensive Care UnitClinical Infectious Diseases, 2010
- Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource UtilizationInfection Control & Hospital Epidemiology, 2010
- A multifaceted program to prevent ventilator-associated pneumonia: Impact on compliance with preventive measures*Critical Care Medicine, 2010
- Ventilator-associated pneumonia and mortality: A systematic review of observational studies*Critical Care Medicine, 2009
- Nosocomial Infection, Length of Stay, and Time-Dependent BiasInfection Control & Hospital Epidemiology, 2009
- SMART Approaches for Reducing Nosocomial Infections in the ICUSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Underresourced Hospital Infection Control and Prevention Programs: Penny Wise, Pound Foolish?Infection Control & Hospital Epidemiology, 2007
- Preventing Ventilator-Associated Pneumonia in AdultsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Clinical and economic consequences of ventilator-associated pneumonia: A systematic reviewCritical Care Medicine, 2005
- Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia*Critical Care Medicine, 2002